| Speakers from |
 |
AstraZeneca
CENSA
Daiichi Sankyo Pharma
EMBL - EBI
Entelos
ETH Zurich
F. Hoffmann-La Roche
Genkyotex
GlaxoSmithKline
Merck KGaA
Novartis
Orion
Pfizer
UCB Group |
|
|
|
|
| Featured Speakers |
|
|
|
Li Chen,
Chief Scientific Officer, Roche R&D Center (China) Ltd
|
 |
|
|
Dr Pele Chong,
Distinguished Investigator and Director, Vaccine R&D Center, NHRI, Taiwan
|
|
|
|
Dr. Li Dong Bei,
Director of Bioanalytical Services Dept., WuxiApptec, China
|
|
|
|
Angela Dunne,
Principal Scientist, GlaxoSmithKiline, Singapore
|
|
|
|
Deborah Hartman,
Vice President, Respiratory and Inflammation Research Astrazeneca Charnwood, Astrazeneca
|
|
|
|
Dr Suchitra Kataria,
Head Business Development and In-Licensing - Regional Strategic Development Asia Pacific, Bayer Schering, Singapore
|
|
|
|
Alex Liu,
Chairman, Golden Biotechnology Corp, Taiwan
|
|
|
|
Dr. Xin Ma,
Head of Global Drug Discovery - Innovation Center China Bayer Schering Pharma
|
|
|
|
Jurgen Moll,
Director, Department of Cell Biology, Oncology, Nerviano Medical Sciences Srl.
|
|
|
|
Shintaro Nishimura,
Vice President, Bioimaging Research Laboratories, Astellas Pharma Inc. Astellas Japan
|
|
|
|
Dr Sudhir Sahasrabudhe,
CEO, Prolexys Pharmaceuticals Inc.
|
|
|
|
Michael Shi,
Director, Biomarker Project Leader Exploratory Oncology Development, Novartis
|
|
|
|
Dr. Erik Sprengers,
Site Head, Schering-Plough, Singapore
|
|
|
|
Swami Subramaniam,
Director, Licensing and External Research, India, merck Sharp and Dohme
|
|
|
|
Dr Greg Tucker-Kellogg,
Cheif Technology Officer and Senior Director, Lilly Singapore Centre for Drug Discovery (Eli Lilly)
|
|
|
|
Prof Uros Urleb,
Global Product Development, Chief Scientific Officer, Sandoz International HmbH
|
|
|
|
Dr Alain van Gool,
Head Molecular Profiling, Translational Medicine Research Centre Singapore, Schering Plough
|
|
|
|
Dr Miro Venturi,
Director Biomarker and Experimental Medicine, Roche Pharma Development
|
|
|
|
Dr Jingsong Wang,
Director of Discovery Medicine & Clinical Pharmacology, Bristol-Myers
|
|
|
|
Stella Xu,
Executive Director, Roche Pharma Partnering, China
|
|
|
|
|
|
